ABBV - CIK 0001551152
AbbVie Inc. (ABBV) reported net income of $4.28B for fiscal year 2024, down 12.0% from $4.86B in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
| Quarter | Period end | net income |
|---|---|---|
| Q1 | 2024-03-31 | $1.37B |
| Q2 | 2024-06-30 | $1.37B |
| Q3 | 2024-09-30 | $1.56B |
| Q4 | 2024-12-31 | -$22.00M |
Calendar quarters as standardized by SEC XBRL frames; the company's fiscal calendar may offset from calendar quarters.
AbbVie Inc. (ABBV) reported net income of $4.28B for fiscal year 2024, down 12.0% from $4.86B in fiscal 2023. The figure comes from the company's audited annual report as filed with the SEC.
In the following fiscal year (2025), AbbVie Inc. reported net income of $4.23B, a decrease from the $4.28B reported in fiscal 2024.
See the full ABBV net income history or the complete income statement.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.